🇺🇸 FDA
Pipeline program

Ketamine Hydrochloride

STUDY22010164

Phase 3 small_molecule active

Quick answer

Ketamine Hydrochloride for Traumatic Injury is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Traumatic Injury
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials